Cineworld Dividends - CINE

Cineworld Dividends - CINE

Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
Monthly Subscription
for only
UK/US Silver
Monthly Subscription
for only
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Cineworld Group Plc CINE London Ordinary Share GB00B15FWH70 ORD 1P
  Price Change Price Change % Stock Price High Price Low Price Open Price Close Price Last Trade
  -4.40 -1.95% 221.40 226.10 220.80 225.10 225.80 16:35:01
more quote information »
Industry Sector

Cineworld CINE Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount

Top Dividend Posts

clanger66: I agree, it's all very well watching a blockbuster movie on your TV but even with the advances in TV picture and sound quality its not the same as watching on the big screen. OK you have to deal with the annoying person next to you rustling their sweet wrappers but I can live with that.All I ever hear about is that people value experiences more than physical things so I don't envisage the cinema dying out soon, but maybe evolving to offer something more.Incidentally, just looked at Everyman which according to people I know who've been, it's a great experience. I had previously looked at the stock but it was too expensive for me, however looking at its recent share price performance the market quite likes it.Cineworld as far as I'm concerned looks massively undervalued.
williamcooper104: The fluctuations in film releases is just noise - but it's always moved the share price - I've held Cine since 2009 until a few weeks ago Sold because 1 special dividend - would rather they invested or paid down debt 2 competition in UK getting better or rather much less worse than it used to be - eg odeon 3 Netflix/changing industry dynamics as the big studios all go streaming - this has always been a fear and never realised Still keeping a watch on the stock - I've done v v well holding them over the years I
philanderer: The note: 'Peel Hunt: buying opportunity at Cineworld' Peel Hunt has upgraded Cineworld (CINE), arguing the investment case is still intact despite the share price reflecting profit concerns. Analyst Ivor Jones upgraded his recommendation from ‘add’ to ‘buy’ but lowered the target price from 320p to 300p. The shares fell 1.4% to 251.6p yesterday. ‘Next week’s interims will show the impact on profits of a weaker release schedule. This may explain the recent weakness in the share price,’ said Jones. ‘With the investment case intact, strong film releases ahead, and the majority of the earnings in US dollars, we see the current share price as a buying opportunity.’
srichardson8: It seems to me that the current management are doing an excellent job although their investor relations are pathetic. The underlying problem is that going to the movies is seeing more and more competition from alternative visual entertainment. We all know that. So one doesn't expect very high market ratings. The odd thing is just how low those (forward) ratings appear to have gone. The share went ex a total dividend package of 26.9p equivalent in two stages - 10.9p on June 14 and the large special dividend of 16p on June 21st. But most of the share retreat was up to these dates, not after. This suggests that there were some perhaps clever arbitrages to capture the income using derivatives and I am bound to notice Morgan Stanley, a past master at arbitrage trading, announcing its release of voting rights which will probably indicate an exit from an option strategy. The RBC comments seem to me a complete red herring. The fact is that the company has already taken on a load of debt when it bought Regal, the usual ploy of private equity pirates. One of the strategies for relieving the debt burden is the sale and leaseback of freehold US cinemas, the other is cashflow from the cinema estate. Success or otherwise in the latter category is what, in my view, will determine if this share price is heavily oversold at this level - which I believe to be the case.
lukmanpatel: Another troll by the username lsehotdealz haha, share price is stagnant and there’s talks of fundraise at 10p on that board lol desperation has lead to going round posting on different board to prevent share price from dropping, usually ud stay quiet and average down and accumulate if you see huge potential lmaoo he’s spamming all the boards
nav_mike: Its all in here :) Rump = the block of shares that were not taken up under the rights issue, and subsequently placed in the market by the underwriters
hyden: royjs, the 2014 rights issue shares were placed at 338p so less the deduction of the 230p issue price leaves 108/p per share. See the link below hTTps:// Your fiancé should therefore have received a cheque for 108p per right less dealing costs. In my opinion, she is entitled to the money and has a valid claim. 2014 is certainly not too long ago in law so she can still pursue this. The company in question must have kept records as they are legally required to do so. If need be, you will be able to take the matter to the financial ombudsman who will also award interest on top (at 8% pa, I believe).
sharw: royjs - I think you are confusing us by saying that you have missed a date. The first question is whether your shares are in a nominee a/c or certificated. The fact that you have been talking to the registrar Link suggests the latter. The complex timetable is set out in full some way down the announcement: You say you missed the 9th but that was a special facility: Latest time for receipt of instructions under the Special Dealing Service in respect of Cashless Take-up or disposal of Nil Paid Rights 3.00 p.m. on 9 February 2018 The next main deadline is: Latest time and date for acceptance, payment in full and registration of renunciation of Provisional Allotment Letters 11.00 a.m. on 19 February 2018 So assuming you are in certificates you have two options left - pay 157p per rights share by that deadline or do nothing. If you do nothing the rights shares will automatically be sold on your behalf and you will receive the share price less 157 less expenses. This has all been explained on this thread before - you may wish to calmly read through starting here: Remember - as Mozy123 says this can't make you worse off.
grahamburn: Re the earlier posts on the relative mismatch in the sizes of Cineworld and Regal. It shouldn't be forgotten by old hands that back in 2014 when Cineworld theoretically "took over" the business controlled by the Greidingers (can't remember its name offhand), it was really the other way round as the Greidingers jumped into the top management seats. That might set a precedent for the deal with Regal because the Greidingers' business in Israel and eastern Europe was much smaller than Cineworld at that time. In short, the Greidingers have past form of seeming to biting off more than they can chew, but then turning the combined businesses into something much bigger. However, having said that, the nominal size of Regal's debts does appear to be high, though any eventual deal could be structured to take care of that aspect. However, that could be a bigger ask after today's share price fall as any rights issue will be harder to get away. Right now, the jury's out. If the putative deal falls, then the share price will undoubtedly bounce back though not necessarily to where it was yesterday as the Greidingers' reputations will have taken a knock. On the other hand, the share price could also recover a little if the deal is well structured in Cineworld's favour, not to mention in shareholders' favour as well in terms of a decent rights issue discount.
lauders: Well this is confusing! Below are both notes from the same "broker" a week apart. Nothing like confusing your clients! Perhaps one client liked the original one so much and agreed so much they convinced Canaccord to issue another contrary one so they could load-up! Surely the FSA should look into obvious cases like this? Seems crazy! Canaccord has latched onto Bond-mania with the release of Sceptre, the latest film in the long-running franchise, on Monday to repeat its ‘buy’ rating on cinema chain Cineworld (LON;CINE). But it is the less racy expansion opportunity for the chain in eastern Europe that has got the broker’s juices running. An analysts’ trip to Romania confirmed the commanding position in a growing market held by Cineworld in a country where there is little competition said the broker. Subsidiary Cinema City operates 21 of 34 multiplexes in Romania with plans to take it to 40 multiplexes in the next five years. Cineworld also makes more money per pound of investment in Romania that anywhere else. The 40 multiplex target is realistic, believes Canaccord, as Romania has a population of 20mln and there are 23 cities with a population of over 100,000. James Bond and Star Wars excitement meanwhile has led to problems coping with the demand. Canaccord said Cineworld had confirmed its website had crashed along with its rivals due to the surge of interest, with as many ticket requests for Star Wars in a day as normally come in over three months. Buy with a 620p target price says the broker. Cannacorde note....We are reducing our Cineworld recommendation to SELL from Buy with a new, lowered share price target of 535p (from 620p), implying c10% downside. It’s time to take profits. Cineworld’s share price is up 75% over the last 12 months driven in large part by this year’s fantastic film slate that climaxes this quarter with three blockbusters: Bond Spectre, Hunger Games: Mockingjay Part 2 and Star Wars: the Force Awakens yet Cineworld traditionally under-indexes versus Odeon and Vue on blockbusters and our research suggests this quarter will be no exception. This quarter is as good as it gets for the cinema industry. Next year's film slate is less strong and it could be a 'crowded trade' when the market wakes up to a duller outlook not helped by the distractions of the Olympics and the UEFA European Football Championships next summer.Our analysis round the three autumn blockbusters shows that Odeon is more aggressive on the allocation of screens and Vue is more aggressive on price. Cineworld does not believe in revenue yield optimization. Until it does, we believe it will continue to underperform during industry peaks. We are coming to the view that Cineworld is better at building cinemas in unsophisticated East Europe where competition is weak than optimizing performance from its sophisticated UK portfolio where competition is intense. We estimate Cineworld could be missing out on as much as £2.2m of additional EBITDA per blockbuster in the UK. Assuming a blockbuster/quarter that puts Cineworld’s missed UK opportunity at £8.8m. For 4Q15, with three potential blockbusters, the scale of the missed opportunity may be as much as £6.6m. To put this in context, the UK accounts for c65% of Cineworld EBIT and we are forecasting an H2 EBIT contribution of £44.7m for the UK and £65.4m for group EBIT. It’s a very material lost opportunity for Cineworld. Potential year-end upgrades should not be mistaken for an excellent performance: a rising tide lifts all ships. Our new 535p target price valuation is equivalent to 18.8x PER, 10.0x EV/EBITDA, an 8.0% FCF yield and 3.0% dividend yield for FY15E. The current share price of 594p values the stock on a P/E of 20.9x for FY15E, 18.9x FY16E, an EV/EBITDA of 10.9x falling to 10.0x, a FCF yield of 7.2% rising to 7.9% and dividend yield of 2.7% rising to 2.9% over the same period. It now looks an expensive stock following its re-rating over the last 12 months. Anyone else confused?
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191023 02:44:13